Blog
RSS FeedPosted by Michael Wonder on 27 May 2019
NHS England wants money back guarantee on Orkambi
24 May 2019 - Vertex resisting real-world data proposal. ...
Posted by Michael Wonder on 26 May 2019
Calls for 'life changing' drug Aimovig on NHS in England
24 May 2019 - People who suffer from chronic migraines are calling for a new drug to be offered on ...
Posted by Michael Wonder on 21 May 2019
The global battle over high drug prices
21 May 2019 - Western countries, as well as poor ones, are demanding transparency in the cost of drugs. ...
Posted by Michael Wonder on 20 May 2019
Theresa May urges US makers of cystic fibrosis drug to strike ‘crucial’ deal with NHS
17 May 2019 - Theresa May last night urged US makers of a drug that prolongs life for cystic fibrosis sufferers ...
Posted by Michael Wonder on 18 May 2019
NICE recommends Revlimid as multiple myeloma alternative
17 May 2019 - NICE has recommended Revlimid (lenalidomide), a drug that helps to support the immune system to fight ...
Posted by Michael Wonder on 16 May 2019
Mum delivers 65 roses to Downing Street in bid to speed up NHS availability of vital cystic fibrosis drugs
16 May 2019 - Calls for NHS access to potentially life-saving drugs are growing, one year to the day after ...
Posted by Michael Wonder on 15 May 2019
Cystic fibrosis drug campaign makes no progress in year
10 May 2019 - It is a year on from the delivery of more than 1,000 letters to Downing Street, ...
Posted by Michael Wonder on 13 May 2019
HTA frameworks for RA therapies need improvement, researchers say
13 May 2019 - Cost-effectiveness models for the treatment of rheumatoid arthritis first emerged in the early 2000s when highly effective ...
Posted by Michael Wonder on 13 May 2019
The UK’s new medicines pricing deal – opportunities and risks for pharma
10 May 2019 - January 2019 saw the introduction of the new Voluntary Scheme for Branded Medicines Pricing and Access ...
Posted by Michael Wonder on 13 May 2019
MPs call for 'life-changing' Kuvan to be made affordable
11 May 2019 - A number of MPs are calling on a drug company to make a "life-changing" treatment affordable ...
Posted by Michael Wonder on 09 May 2019
Lower price for MS drug paves the way for positive recommendation from NICE
9 May 2019 - A new, lower price for a drug to treat a rarer form of multiple sclerosis in adults ...
Posted by Michael Wonder on 09 May 2019
Hope for multiple sclerosis sufferers after green light for drug which can delay wheelchair use by seven years
9 May 2019 - Multiple sclerosis patients have welcomed an NHS decision to fund a “landmark” drug which can delay ...
Posted by Michael Wonder on 03 May 2019
NICE recommends Roche’s Tecentriq for metastatic NSCLC
3 May 2019 - NICE has published final draft guidance recommending Roche’s Tecentriq in combination with other therapies for metastatic ...
Posted by Michael Wonder on 01 May 2019
Drug maker Takeda to introduce value-based pricing in Europe
29 April 2019 - Japanese company to refund Crohn's disease patients with no improvements. ...
Posted by Michael Wonder on 01 May 2019
NHS England finalises procurement to eliminate hepatitis C
1 May 2019 - After lengthy negotiations and a court battle, NHS England has reached agreement with three drug companies ...